A novel blood test appears to hold promise for detecting an array of cancers, such as hematologic malignancies and solid tumors, in otherwise healthy people.
In 6,000 participants, the test showed impressive specificity. Among the small proportion with a positive finding, many proved to be false positives, but cancer could be ruled out in most without invasive testing, while false negatives appeared to be rare. The findings were reported at the 2022 annual meeting of the European Society for